Month: May 2020

AUSTIN, Texas, May 14, 2020 (GLOBE NEWSWIRE) — Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the first quarter March 31, 2020.“Despite late first quarter challenges from COVID-19, we delivered strong first quarter revenue and test volume growth year over year. In fact, test volume was only down 5% as compared to the fourth quarter 2019. Delivering surgical triage results to physicians during this period of operation room rationing and backlog is essential,” said Valerie Palmieri, Chief Executive Officer of Vermillion.“We are starting to see patients return to their providers and test volumes rebound. OVANex and Endocheck study site recruitment also continues and we do not expect a significant delay in our product pipeline. In...

PHILADELPHIA, PA, May 14, 2020 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ:FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens and beyond, today announced that it will hold its Annual Shareholder Meeting as a virtual meeting as a result of continuing concerns surrounding COVID-19. The meeting will still be held on Tuesday, June 16, 2020 at 9:00 am ET, as previously announced. Shareholders will not be able to attend the Annual Meeting physically. Shareholders are entitled to participate in the virtual Annual Meeting, post questions, and vote their shares, if they were a shareholder of record as of the close of business on April 21, 2020, the record date, or hold a legal proxy for the meeting provided by the shareholder’s bank, broker, or nominee.Attending the Annual MeetingTo attend and participate in the...

ORLANDO, Fla., May 14, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, reported its financial and operational results for the first quarter ended March 31, 2020.Q1 2020 Financial Summary Compared to Q1 2019Total revenue was the same at $4.8 million in each quarter.Managed Services revenue increased 7% to $4.1 million, compared to $3.9 million.SaaS Services revenue decreased 36% to $583,000, compared to $913,000.Total Gross Billings* decreased 22% to $6.1 million, compared to $7.8 million.Total costs and expenses were $10.9 million, compared to $6.5 million. Increase driven by a $4.3 million impairment of goodwill in Q1 2020.Net loss was $6.2 million, compared to a net loss of $1.8 million.Adjusted EBITDA* was...

BURNABY, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2020 financial and operating results after the close of U.S. financial markets on Thursday, May 21, 2020.  Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) to discuss the results and to provide a corporate update.To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 8385218. The webcast will be broadcast live on the “Investors” section of Xenon’s website at www.xenon-pharma.com and will be available for replay following the call for 30 days.About Xenon Pharmaceuticals Inc.

Quarterly revenue of $3.96 billion, up 12 percent year over yearGAAP EPS of $0.82 and non-GAAP EPS of $0.89, up 17 percent and 27 percent year over year, respectivelyReturned $392 million to shareholdersSANTA CLARA, Calif., May 14, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. (NASDAQ: AMAT) today reported results for its second quarter ended Apr. 26, 2020.Second Quarter ResultsApplied generated revenue of $3.96 billion. On a GAAP basis, the company recorded gross margin of 44.2 percent, operating income of $932 million or 23.6 percent of net sales, and earnings per share (EPS) of $0.82.On a non-GAAP adjusted basis, the company reported gross margin of 44.6 percent, operating income of $976 million or 24.7 percent of net sales, and EPS of $0.89.The company returned $392 million to shareholders including $199 million in share repurchases...

Duchenne Muscular Dystrophy Program-Final Top-Line 12-month Results from Phase II Randomized, Double-blind, Placebo-controlled HOPE-2- Study Demonstrated Improved Performance of Upper Limb (PUL) 2.0 (p=0.05)-COVID-19 Program-COVID-19 Compassionate Use Case Series Published in Peer Reviewed Journal--Reported 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002 Under Compassionate Use Pathway--Expanded Access Protocol Approved by FDA to Treat Critical COVID-19 Patients-            -Appointed Stephen J. Gould, Ph.D. to lead Capricor’s Exosome-Based Platform Vaccine Approach Against COVID-19--To Host Conference Call and Webcast Today at 4:30 p.m. ET-LOS ANGELES, May 14, 2020 (GLOBE NEWSWIRE) — Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class...

EVERETT, Wash., May 14, 2020 (GLOBE NEWSWIRE) — Coastal Financial Corporation (NASDAQ: CCB), the parent company of Coastal Community Bank, has been awarded the Raymond James Community Bankers Cup for 2019.The eighth annual Raymond James Community Bankers Cup recognizes the top 10% of community banks in the nation. Of the 255 community banks considered for the award, the top 10% demonstrated superior performance on a relative basis in one or more of the following measurements of financial performance and stability:Nonperforming assets to loans and real estate ownedFive-year average core deposit percentageNet interest marginEfficiency ratioReturn on average assetsReturn on average tangible common equity“This is the first year Coastal Financial Corporation has received this award and it’s a huge honor,” said Eric Sprink, President...

David Orme, senior vice president of sales and marketing of IDEX Biometrics, purchased 3,000 shares in the market on 14 May 2020 at NOK 1.75 per share. Following this transaction, Mr. Orme owns 203,000 shares and 2,208,600 incentive subscription rights in IDEX.For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186Derek D’Antilio, Chief financial OfficerE-mail: derek.dantilio@idexbiometrics.comTel: +1 197 827 31344About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all.  We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger.  We invent,...